Novo Nordisk Drugs

Signal: Novo Nordisk market cap higher than Dan...

China OKs Novo Nordisk's Type-2 diabetes treatm...

Novo Nordisk submits diabetes pill for US approval

Novo Nordisk

Novo Nordisk launches once-a-week diabetes drug...

Novo Nordisk experience big profit rise due to ...

Novo Nordisk’s Global Commitment to Diabetes Ca...

Novo Nordisk

Novartis' Sandoz dips on debut after lower than...

Novo Nordisk amplía sus fármacos contra la obes...

Novo Nordisk Logo Png

Novo Nordisk Posts Record Growth as Demand For ...

FID prosigue su larga colaboración con Novo Nor...

Novo Nordisk hits all-time high as oral obesity...

Novo Nordisk Research Centre opens in Oxford | ...

Novo Nordisk to test anti-obesity molecule in t...

Novo Nordisk's results are stunning - and it co...

Is Novo Nordisk Stock a Buy After its Collapse?...

Novo Nordisk leaps on new obesity drug data | p...

Novo Nordisk A/S Sees Unusually Large Options V...

NOVO NORDISK INC.: Novo Nordisk Launches Ozempi...

First: Novo Nordisk India launches oral Semaglu...

Novo Nordisk Logo Png

Novo Nordisk receives FDA approval for Wegovy™

Novo Nordisk - la compañia que trata la diabete...